The Blood Screening Market report provides a detailed analysis of the industry by market size in terms of revenue, market share and growth opportunities. It also covers the latest trends and drivers and studies the segments with respect to the different regions and countries. Furthermore, it also highlight on the recent development, product overview, and financial details of leading...

The global blood screening market was valued at USD 3.40 billion in 2024, and it is expected to grow at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. The market's rapid expansion is primarily driven by the increasing number of blood donations worldwide, which necessitates stringent screening protocols to ensure the safety of blood and detect transfusion-transmissible...

The blood screening market is pivotal in ensuring the safety of blood transfusions and early disease detection. Here's an overview of its recent developments, market dynamics, segment analysis, and key market players: The global blood screening market was valued at USD 2.99 billion in 2023 and is anticipated to grow at a CAGR of 11.6% from 2024 to 2033. Ensuring blood supply safety...

Blood Screening Market Highlights: The blood screening market is witnessing significant growth, largely driven by the increasing demand for comprehensive panel blood tests. A comprehensive panel blood test, also known as a full blood panel or complete blood count (CBC), is a diagnostic test that evaluates various components of the blood, including red blood cells, white blood cells, platelets,...

The Blood Screening Market is experiencing a paradigm shift in healthcare diagnostics, marked by advancements in segmentation, size, share, trends, and remarkable growth. As the importance of blood screening in preventing and managing diseases becomes increasingly evident, the market is playing a pivotal role in ensuring the safety and well-being of individuals worldwide. The Blood Screening...

The global blood screening market, valued at USD 3.40 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. This anticipated growth is largely due to a global increase in blood donations, which heightens the need for rigorous screening processes to detect transfusion-transmissible infections and ensure patient safety. Advances in technology,...

Blood Screening Market Highlights: PSA testing is another important component of the blood screening market, particularly in the context of prostate health. PSA testing measures the level of prostate-specific antigen (PSA) in the blood, which can help detect prostate cancer and monitor the effectiveness of treatment in patients with a history of prostate cancer. While PSA testing is not a...

Blood Screening Market Highlights: The blood screening market is witnessing significant growth, largely driven by the increasing demand for comprehensive panel blood tests. A comprehensive panel blood test, also known as a full blood panel or complete blood count (CBC), is a diagnostic test that evaluates various components of the blood, including red blood cells, white blood cells, platelets,...

The global blood screening market was valued at USD 3.40 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. This growth is primarily driven by an increasing number of blood donations worldwide, which requires stringent screening protocols to prevent the transmission of infections through transfusions. Technological advancements,...

Blood Screening Industry Overview   The global blood screening market size is expected to reach USD 6.62 billion by 2030, registering a CAGR of 11.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increase in screening of donor and continuous technological advancement by the market players. Demand for...